New Product Newswire
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1
The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis
This approval offers pediatric patients and caregivers the first subcutaneous option that can be administered at home.
FDA Approves Dupilumab for Treatment of Bullous Pemphigoid
Bullous pemphigoid is a rare skin condition that causes large blisters filled with fluids that typically occur near skin creases, such as the upper thighs and armpits.
FDA Approves Nitisinone for Treatment of Alkaptonuria
Alkaptonuria affects approximately 1 in 250,000 to 1 million people in the United States.
FDA Approves New Moderna COVID-19 Vaccine for Older Adults, High-Risk Patients
The new approval is in line with recommendations that suggest booster vaccination for older adults and patients aged 12 to 64 with at least 1 or more underlying risk factors.